Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Departments of Pediatrics and Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Gut. 2019 Mar;68(3):487-498. doi: 10.1136/gutjnl-2017-314426. Epub 2018 Jan 23.
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise from ductal cells via pancreatic intraepithelial neoplasia (PanIN) precursor lesions. Modelling of different genetic events in mice suggests both ductal and acinar cells can give rise to PDAC. However, the impact of cellular context alone on tumour development and phenotype is unknown.
We examined the contribution of cellular origin to PDAC development by inducing PDAC-associated mutations, Kras expression and loss, specifically in ductal cells ( (' ')) or acinar cells ( (' ')) in mice. We then performed a thorough analysis of the resulting histopathological changes.
Both mouse models developed PDAC, but mice developed PDAC earlier than mice. Tumour development was more rapid and associated with high-grade murine PanIN (mPanIN) lesions in mice. In contrast, mice exhibited widespread metaplasia and low-grade as well as high-grade mPanINs with delayed progression to PDAC. Acinar-cell-derived tumours also had a higher prevalence of mucinous glandular features reminiscent of early mPanIN lesions.
These findings indicate that ductal cells are primed to form that become invasive PDAC in the presence of oncogenic Kras and deletion, while acinar cells with the same mutations appear to require a prolonged period of transition or reprogramming to initiate PDAC. Our findings illustrate that PDAC can develop in multiple ways and the cellular context in which mutations are acquired has significant impact on precursor lesion initiation, disease progression and tumour phenotype.
胰腺导管腺癌(PDAC)被认为是一种高度侵袭性肿瘤,起源于导管细胞,通过胰腺上皮内肿瘤(PanIN)前体病变。在小鼠中对不同遗传事件的建模表明,导管细胞和腺泡细胞均可导致 PDAC 的发生。然而,单独的细胞背景对肿瘤发展和表型的影响尚不清楚。
我们通过在小鼠中特异性诱导与 PDAC 相关的突变、Kras 表达缺失和缺失,分别在导管细胞(“”)或腺泡细胞(“”)中检测细胞起源对 PDAC 发展的贡献。然后,我们对由此产生的组织病理学变化进行了全面分析。
两种小鼠模型均发展为 PDAC,但 小鼠比 小鼠更早发展为 PDAC。在 小鼠中,肿瘤发展更快,与高级别小鼠 PanIN(mPanIN)病变相关。相比之下, 小鼠表现出广泛的化生以及低级别和高级别 mPanIN,其向 PDAC 的进展延迟。腺泡细胞来源的肿瘤也更常出现黏液性腺泡特征,类似于早期 mPanIN 病变。
这些发现表明,在致癌 Kras 和缺失存在的情况下,导管细胞被预先设定为形成侵袭性 PDAC,而具有相同突变的腺泡细胞似乎需要较长的过渡或重编程期才能启动 PDAC。我们的研究结果表明,PDAC 可以以多种方式发展,并且突变发生的细胞背景对前体病变的起始、疾病进展和肿瘤表型有重大影响。